- Title
- Cantharidin analogues: synthesis and evaluation of growth inhibition in a panel of selected tumour cell lines
- Creator
- McCluskey, Adam; Ackland, Stephen P.; Bowyer, Michael C.; Baldwin, Monique L.; Garner, James; Walkom, Cecilia C.; Sakoff, Jennette A.
- Relation
- Bioorganic Chemistry Vol. 31, p. 66-77
- Publisher Link
- http://dx.doi.org/10.1016/S0045-2068(02)00524-2
- Publisher
- Academic Press
- Resource Type
- journal article
- Date
- 2003
- Description
- Diels–Alder addition of furans (furan, furfuryl alcohol, and 3-bromofuran) to maelic anhydride yields three distinct 5,6-dehydronorcantharidins. Hydrogenation of (4,10-dioxatricyclo[5.2.1.0]decane-3,5-dione) (4a), in dry ethanol affords the monoester (7-oxabicyclo[2.2.1]heptane-2,3-dicarboxylic aid monoethyl ester) (6). Subsequent transesterification affords a series of monoesters (7-oxabicyclo[2.2.1]heptane-2,3-dicarboxylic acid monomethyl ester (7)), 7-oxabicyclo[2.2.1]heptane-2,3-dicarboxylic acid monopropyl ester (8), (7-oxabicyclo[2.2.1]heptane-2,3-dicarboxylic acid monohexyl ester (9)) and differentially substituted diesters (7-oxabicyclo[2.2.1]heptane-2,3-dicarboxylic acid 2-ethyl ester 3-isopropyl ester) (10), and (7-oxabicyclo[2.2.1]heptane-2,3-dicarboxylic acid 2-ethyl ester 3-phenyl ester) (11). Analogues were firstly screened for their ability to inhibit protein phosphatases 1 (PP1) and 2A (PP2A) as the lead compounds cantharidin (1) and norcantharidin (2) are known PP1 and PP2A inhibitors. Only analogues 4a, 6–8 displayed good PP1 and PP2A inhibition (PP1 IC50’s=2.0, 2.96, 4.71, and 4.82 μM, respectively; PP2A IC50’s=0.2, 0.45, 0.41, and 0.47 μM, respectively). All analogues were also screened for their anti-cancer potential against a panel of tumour cell lines, HL60, L1210, SW480, WiDr, HT29, HCT116, A2780, ADDP, and 143B, producing GI50 values ranging from 6 μM to >1000 μM. Analogues possessing good PP1 and/or PP2A inhibition also returned moderate to good anti-cancer activity. Analogues with substituents directly attached to the intact bicyclo[2.2.1]heptane skeleton were poor to moderate anti-cancer agents. This correlates well with their lack of PP1 or PP2A activity. Analogues capable of undergoing a facile ring opening of the anhydride or with a single carboxylate were good PP1 and PP2A inhibitors, largely correlating to the observed anti-cancer activity in all cases, except 11. Analogue 11, whist neither a PP1 nor a PP2A inhibitor shows anti-cancer activity comparable to 1 and 2. We believe that intracellular esterases generate the corresponding dicarboxylate, which is a potent PP1 and PP2A inhibitor, and that it is this species which is responsible for the observed anti-cancer activity.
- Identifier
- uon:1773
- Identifier
- http://hdl.handle.net/1959.13/27539
- Identifier
- ISSN:0045-2068
- Reviewed
- Hits: 4896
- Visitors: 3805
- Downloads: 0
| Thumbnail | File | Description | Size | Format |
|---|